Guillaume Harmange, Ph.D.

I am a Principal Scientist at Ipsen, primarily working on the Oncology Search & Evaluation team to identify, evaluate, and execute strategic in-licensing opportunities, while also contributing to internal Discovery programs across the biology and biochemistry teams.

I received my Ph.D. from the University of Pennsylvania for research conducted in the Shaffer Lab, investigating non-genetic mechanisms of targeted therapy resistance in melanoma. My doctoral work coupled wet-lab experimentation with computational analyses, using single-cell RNA sequencing and cellular barcoding to trace transcriptional memory and cell-state plasticity.

Prior to graduate school, I was a Summer Fellow at Flagship Pioneering, focused on biotechnology venture ideation. I received my undergraduate education from Northeastern University, majoring in Biochemistry with a minor in Entrepreneurship. During my undergraduate studies, I conducted research in the Slavov Lab, contributing to the development of single-cell proteomics methodologies (SCoPE-MS), and worked on therapeutic gene-editing biochemistry at Editas Medicine.